SCHEMBL17489153

SCHEMBL17489153

Cc1nc2c(F)cc(-c3nc(Nc4ccc(C5=CCN(C)CC5)cn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.68
CDK2 P24941 15/20 0.68
CDK6 Q00534 15/20 0.68
CDK1 P06493 12/20 0.68
CDK7 P50613 6/20 0.68
CDK9 P50750 6/20 0.68
CCNB1 P14635 9/20 0.63
CCNE1 P24864 9/20 0.63
CCNA2 P20248 3/20 0.63
CCND3 P30281 3/20 0.63
CCNT1 O60563 2/20 0.63
EGFR P00533 2/20 0.63
NTRK1 P04629 2/20 0.63
BRAF P15056 2/20 0.63
KDR P35968 2/20 0.63
MAPK8 P45983 2/20 0.63
CCNH P51946 2/20 0.63
MNAT1 P51948 2/20 0.63
MAPK10 P53779 2/20 0.63
CDK5 Q00535 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17489069 0.86 CDK4 (0.68) CDK4CDK2CDK6CDK1CDK7
SCHEMBL17489142 0.86 CDK4 (0.68) CDK4CDK2CDK6CDK1CDK7
SCHEMBL17485410 0.85 CDK4 (0.63) CDK4CDK2CDK6CDK1CDK7
SCHEMBL17488861 0.85 CDK4 (0.63) CDK4CDK2CDK6CDK1CDK7
SCHEMBL25649450 0.84 CDK4 (0.70) CDK4CDK2CDK6CDK1CDK7
SCHEMBL22003433 0.83 CDK4 (0.70) CDK4CDK2CDK6CDK1CDK7
SCHEMBL22004093 0.83 CDK4 (0.70) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19088957 0.81 CDK4 (1.00) CDK4CDK2CDK6CDK1CDK7
SCHEMBL17477118 0.81 CDK4 (0.69) CDK4CDK2CDK6CDK1CDK7
SCHEMBL17477265 0.81 CDK4 (0.56) CDK4CDK2CDK6CDK1CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed